IFNL3 and chronic hepatitis: Clinically relevant parameters included IL28B polymorphism CC genotype, mild-moderate active chronic hepatitis (Ishak index 6/18) with moderate portal/peri-portal hepatic fibrosis (fibrosis stages 2-3/6).